Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2007
09/27/2007WO2007109523A2 Stabilized ophthalmic compositions comprising oxidatively unstable components
09/27/2007WO2007109303A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
09/27/2007WO2007108749A1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents
09/27/2007WO2007108505A1 Erythropoietin solution preparation
09/27/2007WO2007108463A1 Solid preparation having improved solubility
09/27/2007WO2007108031A2 An ophthalmic pharmaceutical composition containing amphiphilic polyaspartamide copolymers
09/27/2007WO2007108016A1 Preparation of micro or nano systems based on inorganic oxides with controlled porosity for carrying biologically active or activable substances
09/27/2007WO2007107764A1 Reversibly inhibited antibodies for immune cell stimulation
09/27/2007WO2007107706A2 Dimers of heterocyclic compounds for the treatment of copd
09/27/2007WO2007107161A2 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
09/27/2007WO2007107012A1 Reverse phase osteoconductive composition
09/27/2007WO2007106997A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
09/27/2007WO2007017331A3 Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
09/27/2007WO2006043083A8 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
09/27/2007WO2005099751A3 Apparatus and method for transdermal delivery of influenza vaccine
09/27/2007WO2005018623A3 Parenteral and oral formulations of benzimidazoles
09/27/2007US20070225617 Standardized swallow challenge medium
09/27/2007US20070225613 Method of esophageal function testing with a standardized thixotropic swallow challenge medium
09/27/2007US20070225380 Parakeratosis Inhibitor and Skin Preparation for External use
09/27/2007US20070225379 Analgesic, Parkinson or Alzheimer drug in a solvent system containing a monoalkyl ether of diethylene glycol, a glycol, and a mixture of a C2 to C4 alcohol and water; inhibits crystallization and transfer to clothing, improves and modulates bioavailability within skin layers; nonocclusive, semi-solid
09/27/2007US20070225361 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225359 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225358 Dimeric compounds and thier use as anti-viral agents
09/27/2007US20070225311 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor;
09/27/2007US20070225255 Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers
09/27/2007US20070225234 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
09/27/2007US20070225211 Methods and Formulations for Increasing Intestinal Function
09/27/2007US20070225205 Interferon-alpha polypeptides and conjugates
09/27/2007US20070225204 Interferon-alpha polypeptides and conjugates
09/27/2007US20070224278 Triamcinolone composition; injected into eye; stability; mixture of corticosteroid particles and sodium hyaluronate in aqueous carrier
09/27/2007US20070224274 Polymer Particles Containing Active Agents
09/27/2007US20070224272 Method and composition for burned skin
09/27/2007US20070224268 Process for preparing oral calcium compositions
09/27/2007US20070224265 Tablet Comprising Branched Chain Amino Acid and Method for Producing the Same
09/27/2007US20070224256 unit dosage form containing a pharmaceutically acceptable carrier and synthetic or semi-synthetic phosphatidylserine-carrying bodies having a three-dimensional structure, sized and shaped to resemble apoptotic cells and apoptotic bodies; useful for treating autoimmune diseases; antiinflammatory agent
09/27/2007US20070224131 Pet chew article
09/27/2007US20070224126 Index and Method of use of Adapted Food Compositions for Dysphagic Persons
09/27/2007US20070222842 Ejection Liquid, Ejection Device, Ejection Cartridge, and Method of Making Droplets From Liquid
09/27/2007DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts
09/27/2007DE102006054260A1 Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung Water-stabilizing composition, process for their preparation and their use
09/27/2007CA2857023A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
09/27/2007CA2647779A1 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
09/27/2007CA2647107A1 Anti-tumor cell antigen antibody therapeutics
09/27/2007CA2647089A1 Association of oleaginous substance with a mixture of at least two cyclodextrins
09/27/2007CA2646934A1 Methods for reducing protein aggregation
09/27/2007CA2646598A1 Peptide-peptidase inhibitor conjugates and methods of using same
09/27/2007CA2646486A1 Reverse phase osteoconductive composition
09/27/2007CA2646424A1 Stabilized ophtalmic compositions comprising oxidatively unstable components
09/27/2007CA2645855A1 Modified release formulations containing drug-ion exchange resin complexes
09/27/2007CA2645831A1 Anti-tat226 antibodies and immunoconjugates
09/26/2007EP1837040A2 Drug delivery matrices to enhance wound healing
09/26/2007EP1837023A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
09/26/2007EP1837021A2 Inhalative solution formulation containing a tiotropium salt
09/26/2007EP1837019A1 Orally-dispersible pharmaceutical compositions
09/26/2007EP1837015A1 Novel core-shell structure
09/26/2007EP1835939A1 Meningococcal conjugate vaccination
09/26/2007EP1835938A2 Polymer-von willebrand factor-conjugates
09/26/2007EP1835915A2 Immune response modifier formulations and methods
09/26/2007EP1835906A1 Injectable or orally deliverable formulations of azetidine derivatives
09/26/2007EP1835892A2 Chewable oral compositions containing an anti-microbial agent and methods of formulating the compositions to have acceptable germ kill properties and taste
09/26/2007EP1835890A2 Nanoparticulate candesartan formulations
09/26/2007EP1835888A1 Cholanic acid-chitosan complex forming self-aggregates and preparation method thereof
09/26/2007EP1753461B1 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide
09/26/2007EP1735006B1 Polymer particles containing active agents
09/26/2007EP1532981B1 Stable eye drops containing latanoprost as the active ingredient
09/26/2007EP1501485B1 High drug load tablet
09/26/2007EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c
09/26/2007EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
09/26/2007EP1313481B1 Pharmaceutical composition comprising condensed indole compound
09/26/2007EP1307187B1 Use of 13-cis retinoic acid for the treatment of emphysema
09/26/2007EP1301638B1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof
09/26/2007EP1265596B1 Medical emulsion for lubrication and delivery of drugs
09/26/2007EP1140960B1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
09/26/2007CN101044244A Isocyclomaltooligosaccharide, isocyclomaltooligosaccharide synthase, process for producing them and use thereof
09/26/2007CN101044242A Tumor specific antibody
09/26/2007CN101044154A Chimeric molecules for cleavage in a treated host
09/26/2007CN101043908A Complex containing mequitazine, a cyclodextrin and an interaction agent
09/26/2007CN101043907A Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
09/26/2007CN101043906A Compositions and methods for nutrition supplementation
09/26/2007CN101043818A Animal feedstuff dyeing and animal drugs
09/26/2007CN101041079A Novel colloid synthetic vectors for gene therapy
09/26/2007CN101041077A Biphase emulsification adjuvant and the technique for preparing the same
09/26/2007CN101041076A Controlled ointment compound stroma and the preparing method
09/26/2007CN101041075A Biotinylated pulullan polysaccharide nanometer grains and the preparation method
09/26/2007CN101041074A Anticancer compound including neoangiogenesis inhibitors and alkylate agent
09/26/2007CN101041059A Technique of preparing novel soft capsule for soothing the nerves and providing nutrition for the brain
09/26/2007CN101041055A Anti-alcoholism pill
09/26/2007CN101040957A Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same
09/26/2007CN101040950A Method of preparing Ynxingchao dropping pills compound
09/26/2007CN101040933A Compound capsule of vitamin E
09/26/2007CN101040904A Drug for scald and its preparing method
09/26/2007CN101040900A Compound essential oil for treating premature ejaculation
09/26/2007CN101040881A Compound distillate oil for treating impotence
09/26/2007CN101040868A Preparation for regulating release of lithium carbonate, and method for preparing the same
09/26/2007CN101040865A Sustained-released injection including antimetabolite medicine and alkylate agent
09/26/2007CN101040861A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkylate agent
09/26/2007CN101040859A Anticancer compound including anticancer medicine and the synergistic agent
09/26/2007CN101040858A Anticancer compound including taxanes and alkylate agent
09/26/2007CN101040856A Compound agent including moxifloxacin and pidotimod
09/26/2007CN101040855A Compound including rimonabant and poloxamer, solid dispersion and the preparation and the application of the medicine
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 1712